Critics say the answer pharmaceutical companies are pushing to address the ongoing opioid crisis boosts their profits while forcing taxpayers to shoulder the costs.
Dec 15, 2016
0
0
Federal prosecutors have charged two former pharmaceutical executives with fixing prices of generic drugs, part of an ongoing government investigation into anticompetitive tactics by companies that make lower-cost drugs intended ...
Dec 14, 2016
0
0
Drugmaker Pfizer said Monday that it will launch a less-expensive version of rival Johnson & Johnson's blockbuster immune disorder drug, Remicade.
Oct 18, 2016
0
0
Mylan will pay $465 million to resolve accusations from some regulators that it overbilled the federal Medicaid program for the EpiPen allergy medication, the drugmaker announced Friday.
Oct 7, 2016
0
5
Federal officials are encouraging generic drugmakers to develop painkillers that are harder to abuse, the latest in a string of steps designed to combat abuse of highly-addictive pain drugs like codeine and oxycodone.
Mar 24, 2016
0
7
Merck and Sanofi Pasteur are ending their partnership, begun in 1994, to market the drugmakers' vaccines in Europe.
Mar 8, 2016
0
0
Britain's competition authority has fined drugmaker GlaxoSmithKline plc 37.6 million pounds ($54.5 million) for stalling the potential entry of generic competitors of an anti-depressant drug Seroxat into the marketplace.
Feb 12, 2016
0
1
British phamaceuticals giant AstraZeneca revealed Monday that it was in discussions over a deal with cancer drug maker Acerta Pharma.
Dec 14, 2015
0
1
Merck's third-quarter profit more than doubled as heavy cost-cutting more than offset lower sales and the negative effects of a strong dollar.
Oct 27, 2015
0
4
British-based drugmaker GlaxoSmithKline opted Wednesday to keep its stake in its stand-alone HIV business as it set out its strategy following a big deal with Switzerland's Novartis.
May 6, 2015
0
5
